GT Molecular Announces an Ultra-Sensitive RT-PCR Multiplex Panel for Eight Key KRAS G12-G13 Mutations
VAF ≤ 0.03% – Affords digital PCR sensitivity in RT-PCR Suitable for tissue, liquid biopsy, and minimal residual disease (MRD) research applications Translational research testing services available For Research Use Only. Not for use in diagnostic procedures. FORT COLLINS, Colo., June 13, 2024 /PRNewswire/ — GT Molecular, Inc., a leader in developing ultra-sensitive PCR assays for cancer research, pathogen detection, […]